JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conney, A. H.
Right arrow Articles by Kuntzman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conney, A. H.
Right arrow Articles by Kuntzman, R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 154, Issue 2, 310-318, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


DECREASED CENTRAL DEPRESSANT EFFECT OF PROGESTERONE AND OTHER STEROIDS IN RATS PRETREATED WITH DRUGS AND INSECTICIDES

A. H. Conney 1, M. Jacobson 1, W. Levin 1, K. Schneidman 1, and R. Kuntzman 1

1 The Wellcome Research Laboratories, Burroughs Welicome & Co. (USA) Inc., Tuckahoe, New York

Chronic treatment of rats with drugs and insecticides, such as phenobarbital, chlorcyclizine, phenylbutazone, chlordane and dichlorodiphenyltrichloroethane (DDT), stimulates the in vitro hydroxylation of progesterone and other steroids by liver microsomes and markedly decreases the central depressant effects of administered steroid hormones. The decreased central depressant effect of administered progesterone in phenobarbital-pretreated rats is associated with decreased levels of progesterone and its metabolites in the brain. The ability of liver microsomal enzyme stimulators to decrease the central depressant effects of progesterone raises the possibility that liver microsomal enzyme stimulators may also alter physiologic actions of endogenous steroids in the body.

Submitted on March 1, 1966
Accepted on May 16, 1966




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Mesia-Vela, R. I. Sanchez, K. R. Reuhl, A. H. Conney, and F. C. Kauffman
Phenobarbital Treatment Inhibits the Formation of Estradiol-Dependent Mammary Tumors in the August-Copenhagen Irish Rat
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 590 - 597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Conney
Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture
Cancer Res., November 1, 2003; 63(21): 7005 - 7031.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. G. Kokate, M. K. Banks, T. Magee, S.-I. Yamaguchi, and M. A. Rogawski
Finasteride, a 5alpha -Reductase Inhibitor, Blocks the Anticonvulsant Activity of Progesterone in Mice
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 679 - 684.
[Abstract] [Full Text]


Home page
ScienceHome page
A. H. Conney and J. J. Burns
Metabolic Interactions Among Environmental Chemicals and Drugs: Environmental chemicals that alter microsomal activity may influence the safety and efficacy of drugs
Science, November 10, 1972; 178(4061): 576 - 586.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.